for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Consort and Opiant to work on nasal spray overdose treatment

Sept 10 (Reuters) - Consort Medical Plc has agreed to develop a nasal spray for treating opioid overdoses with specialty pharmaceutical company Opiant Pharmaceuticals Inc .

Opiant earlier this year was awarded a $7.4 million grant by the National Institutes of Health’s National Institute on Drug Abuse (NIDA) for the development of a nasally-applied version of overdose treatment nalmefene. (Reporting by Noor Zainab Hussain in Bengaluru; editing by Patrick Graham)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up